Montreal-born, Dr. Yves Lapierre obtained his medical degree from Université de Montreal with highest honors and completed his residency in neurology at McGill University. After spending 2 years in neuroimmunology at Massachussets General Hospital in Boston, he returned to the Sacré-Coeur hospital and Institute Armand Frappier in 1975. Dr. Lapierre joined Dr. Bert Cosgrove at the MS clinic in 1979. In 1981, he became staff neurologist at the Montreal General Hospital and a permanent member of the McGill community.
Dr. Lapierre has been interested in research relating to Multiple Sclerosis (MS) since his early years in training. He has been involved in clinical trials in MS for more than 25 years and believes that clinical research should be intimately linked to more basic research such as immunology, imaging, molecular biology and other emerging fields to provide a better understanding of the disease process and how this may impact on the lives of people with MS.
He was appointed Director of the MS Clinic in 1999 and has systematically increased the number of patients followed at the clinic servicing all regions of Quebec. He is one of the most experienced MS specialist that personally follows one of the largest cohort of patients in Canada.
He has actively advocated for more multidisciplinary services for MS patients at the Montreal Neurological Institute (MNI) MS Clinic and affiliated institutions among the community to increase accessibility to patients. He identified the need for more nursing services and funded a new position with an innovative public health and private industry partnership.
Most recently, Dr. Lapierre was the driving force for the creation of an infusion clinic at the MNI to provide a new therapy for MS in close proximity to all medical services to enhance patient safety.
He hopes to continue to make the clinic more accessible to patients, to broaden its team services and expand into the community forming a MS Clinic network while significantly contributing to knowledge about the natural history of the disease using the MS Clinic database as well as to clinical and fundamental research.